Gyre Therapeutics, Inc. Common Stock, Dividends, Per Share, Cash Paid
Gyre Therapeutics, Inc. (GYRE) reported Common Stock, Dividends, Per Share, Cash Paid of $0.24 per share for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareCashPaid · last filed 2023-10-26
- Gyre Therapeutics, Inc. common stock, dividends, per share, cash paid for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Gyre Therapeutics, Inc. common stock, dividends, per share, cash paid for the quarter ending 2023-06-30 was $0.00.
- Gyre Therapeutics, Inc. common stock, dividends, per share, cash paid for the quarter ending 2023-03-31 was $0.24.
- Gyre Therapeutics, Inc. common stock, dividends, per share, cash paid for the quarter ending 2022-12-31 was $0.00.
- Gyre Therapeutics, Inc. common stock, dividends, per share, cash paid for fiscal 2022 was $1.43.
| Period end | Common Stock, Dividends, Per Share, Cash Paid | Common Stock, Dividends, Per Share, Cash Paid 3 month | Common Stock, Dividends, Per Share, Cash Paid 6 month | Common Stock, Dividends, Per Share, Cash Paid 9 month | Common Stock, Dividends, Per Share, Cash Paid 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $0.24 10-Q · filed 2023-10-26 | $0.24 derived: sum of 4 quarters · filed 2023-10-26 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.24 10-Q · filed 2023-08-14 | $0.24 derived: sum of 3 quarters · filed 2023-08-14 | $1.67 derived: sum of 4 quarters · filed 2023-10-26 | |
| 2023-03-31 | $0.24 10-Q · filed 2023-05-15 | $0.24 derived: sum of 2 quarters · filed 2023-05-15 | $1.67 derived: sum of 3 quarters · filed 2023-10-26 | ||
| 2023-01-12 | $0.24 10-Q · filed 2023-10-26 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.43 derived: sum of 2 quarters · filed 2023-10-26 | $1.43 10-K · filed 2023-03-30 | ||
| 2022-09-30 | $1.43 10-Q · filed 2023-10-26 | $1.43 10-Q · filed 2023-10-26 | |||
| 2022-09-20 | $1.43 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |